Results 11 to 20 of about 34,873 (303)

Positive predictive values of the coding for bisphosphonate therapy among cancer patients in the Danish National Patient Registry [PDF]

open access: yesClinical Epidemiology, 2012
Malene Schou Nielsson,1 Rune Erichsen,1 Trine Frøslev,1 Aliki Taylor,2 John Acquavella,2 Vera Ehrenstein11Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark; 2Center for Observational Research International, Amgen
Nielsson MS   +5 more
doaj   +1 more source

Bisphosphonate conjugation for bone specific drug targeting [PDF]

open access: yesBone Reports, 2018
Bones provide essential functions and are sites of unique biochemistry and specialized cells, but can also be sites of disease. The treatment of bone disorders and neoplasia has presented difficulties in the past, and improved delivery of drugs to bone ...
Kristen B. Farrell   +3 more
doaj   +2 more sources

Regioselective ester cleavage during the preparation of bisphosphonate methacrylate monomers [PDF]

open access: yesBeilstein Journal of Organic Chemistry, 2011
New functional monomers bearing a methacrylate, a bisphosphonate function and, for most, an internal carboxylate group, were prepared for incorporation into copolymers with adhesive or anticorrosive properties.
Kamel Chougrani   +3 more
doaj   +2 more sources

Bilateral Bisphosphonate-related Atypical Femoral Neck Fracture in a Patient with Familial Mediterranean Fever: A Case Report [PDF]

open access: yes, 2022
The authors present a rare case of bilateral bisphosphonate-related femoral neck fracture in a patient with Familial Mediterranean fever. Chronic subclinical inflammation that continues in the attack-free period is thought to cause osteopenia ...
Sibel Balıkçı   +1 more
core   +1 more source

Bisphosphonate-Based Hydrogel with pH-Responsive Minocycline Release Inhibits Microglia/Macrophages of M1 Polarization for Spinal Cord Injury Therapy [PDF]

open access: yes
After spinal cord injury (SCI), the persistent presence of pro-inflammatory microglia/macrophages (M1 phenotype) in injury lesion is one of the major reasons for inducing neuron damage and preventing neurological function recovery.
Yajun Li (240938)   +9 more
core   +9 more sources

Comparison of a Novel Bisphosphonate Prodrug and Zoledronic Acid in the Induction of Cytotoxicity in Human Vγ2Vδ2 T Cells [PDF]

open access: yes, 2020
Increasing attention has been paid to human γδ T cells expressing Vγ2Vδ2 T cell receptor (also termed Vγ9Vδ2) in the field of cancer immunotherapy.
Senju, Hiroaki   +13 more
core   +1 more source

Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis [PDF]

open access: yes, 2010
Bisphosphonates are the leading drugs for the treatment of osteoporosis. In ­randomized controlled trials (RCTs), alendronate, risedronate, and zoledronate have shown to reduce the risk of vertebral, nonvertebral, and hip fractures, whereas RCTs with ...
Graham Russell   +8 more
core   +1 more source

Bisphosphonates for osteoarthritis [PDF]

open access: yesArthritis Research & Therapy, 2011
Synovitis and subchondral bone turnover are associated with pain in osteoarthritis. Bisphosphonates provide tools for investigating these pathogenic mechanisms and also may have therapeutic potential. Translating preclinical findings into new treatments for human osteoarthritis requires a critical appraisal and refinement of animal models ...
Walsh, David A, Chapman, Victoria
openaire   +2 more sources

Dose-Intensity of Bisphosphonates and the Risk of Osteonecrosis of the Jaw in Osteoporosis Patients

open access: yesFrontiers in Pharmacology, 2018
Objective: To examine the incidence rates and association between dose-intensity, stratified by exposure duration, of bisphosphonates and the risk of osteonecrosis of the jaw among Korean osteoporotic patients older than 50 years.
Sung-mok Jung   +2 more
doaj   +1 more source

Can bone turnover markers help to define the suitability and duration of bisphosphonate drug holidays?

open access: yesDrugs in Context, 2020
Background: On stopping bisphosphonate treatment, bone resorption may increase before evidence of a decrease in bone density. Offset of bisphosphonate effect may therefore be monitored by measuring C-terminal telopeptide (CTX) following long-term ...
Louise Statham   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy